Skip to main content

Protagonist Therapeutics

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical enterprise headquartered in Newark, California. The company focuses on the discovery, development, and commercialization of novel peptide-based therapeutics designed to target complex hematological, inflammatory, and rare diseases. Its proprietary technology platform enables the creation of oral and injectable peptide drugs addressing unmet medical needs. Principal revenue is earned through pharmaceutical research collaboration agreements, clinical milestone payments, and co-development partnerships. The enterprise serves specialized clinical researchers and healthcare systems. Protagonist Therapeutics Inc is publicly traded on the Nasdaq Stock Market.

9 of the funds FundTelligence covers report a position in Protagonist Therapeutics.

Legal name
Protagonist Therapeutics Inc
Sector
Health Care
Country
United States
Funds holding it
9

Funds holding Protagonist Therapeutics

Showing the 8 largest of 9 funds holding it.

Loading...